DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (nine amino acids) studied for its potential to promote deep, restorative delta-wave sleep. It is frequently investigated in integrative and functional medicine for its role in stress resilience, hormone regulation, and pain modulation.

While it occurs naturally in the hypothalamus, DSIP is not currently FDA-approved for human treatment, and rigorous large-scale clinical trials are limited.

Key aspects of DSIP include:

• Mechanism: Research suggests it interacts with neurotransmitters to help normalize circadian rhythms and modulate the stress response, often lowering stress-related cortisol.

• Administration: It is typically prepared by compounding pharmacies (where it is known as Emideltide) and administered via subcutaneous injection, usually in the evening.

• Regulatory Status: The FDA actively reviews its compounding status. Online products labeled "for research only" lack quality control and carry significant legal and safety risks.

  
  

Anyone considering using DSIP should do so only under the direct supervision of a qualified healthcare provider. For a deeper look at the science and legal details, explore the comprehensive ⁠Rite Aid DSIP Guide or read the ⁠Innerbody DSIP Rundown.

This product for research use only.